Press release
Prominent Pneumonia Therapeutics Market Trend for 2025: Innovative Approaches To Combating Antibiotic Resistance In Pneumonia Treatment
Pneumonia Therapeutics
The rising prevalence of pneumonia is expected to propel the growth of the pneumonia therapeutics market. Pneumonia, a lung infection, is becoming more widespread due to factors such as aging populations, air pollution, smoking, and the spread of respiratory infections like COVID-19 and influenza. Pneumonia therapeutics are essential in managing pneumonia, using targeted medications and therapies like oxygen support, anti-inflammatory drugs, and symptom management to improve outcomes. The National Center for Biotechnology Information (NCBI) reported that pneumonia affects approximately 120 million people globally each year, with significant mortality rates, especially among young children in developing countries. This growing prevalence drives the demand for effective pneumonia therapeutics.
Get Your Pneumonia Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/report/pneumonia-therapeutics-global-market-report
What growth opportunities are expected to drive the pneumonia therapeutics market's CAGR through 2034?
The pneumonia therapeutics market has expanded rapidly, growing from $10.35 billion in 2024 to $11.49 billion in 2025 at a CAGR of 11.0%. Growth drivers include the rise of drug-resistant strains, increased awareness of pneumonia prevention, a growing elderly and immunocompromised population, expanded vaccination programs, and improved healthcare infrastructure.
The pneumonia therapeutics market is expected to expand significantly, reaching $17.26 billion by 2029 with a CAGR of 10.7%. This growth will be propelled by the increasing prevalence of antibiotic-resistant strains, a growing number of pneumonia cases among aging populations, wider adoption of telemedicine for early diagnosis, rising healthcare expenditures in developing regions, increased funding for infectious disease research, and heightened awareness initiatives. The key trends expected in this period include the development of monoclonal antibodies, inhalable antibiotics, mRNA-based vaccines, AI-powered diagnostic tools, host-targeted therapies, novel immunomodulators, and advancements in rapid point-of-care diagnostics.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21258&type=smp
What are the emerging trends shaping the future of the pneumonia therapeutics market?
In the pneumonia therapeutics market, companies are addressing the challenge of antibiotic resistance and improving patient outcomes by developing innovative antibiotic drugs. For example, in June 2024, Orchid Pharma Limited and Cipla Limited, both based in India, collaborated to introduce cefepime-enmetazobactam, an antibiotic combination for treating complex infections such as pneumonia and urinary tract infections (UTIs). This combination targets resistant bacteria, offering an effective solution for infections that are resistant to other antibiotics, thereby improving treatment efficacy and reducing the need for stronger antibiotics.
Which growth-oriented segments of the pneumonia therapeutics market are leading the industry's development?
The pneumonia therapeutics market covered in this report is segmented -
1) By Product: Drugs, Vaccine, Oxygen Therapy
2) By Infection: Hospital-Acquired Pneumonia (HAP), Community-Acquired Pneumonia (CAP), Ventilator-Associated Pneumonia (VAP)
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
4) By End Use: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Drugs: Antibiotics, Antiviral Drugs, Antifungal Drugs, Corticosteroids, Other Drugs
2) By Vaccine: Pneumococcal Vaccines, Haemophilus Influenzae Type B (Hib) Vaccines, Influenza Vaccines, Other Vaccines
3) By Oxygen Therapy: High-Flow Nasal Cannula (HFNC), Non-Invasive Ventilation (NIV), Mechanical Ventilation, Other Oxygen Therapies
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21258
What regions are leading the charge in the pneumonia therapeutics market?
North America was the largest region in the pneumonia therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pneumonia therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What companies are at the forefront of innovation in the pneumonia therapeutics market?
Major companies operating in the pneumonia therapeutics market are Pfizer Inc., Roche AG, Merck & Co. Inc., AbbVie Inc, Bayer AG, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, Novartis AG, GSK plc, Eli Lilly and Company, Astellas Pharma Inc., Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Hikma Pharmaceuticals PLC, Shionogi & Co. Ltd, Lupin Limited, Swedish Orphan Biovitrum AB, Nabriva Therapeutics plc, TaiGen Biotechnology Co. Ltd, Aridis Pharmaceuticals Inc., Tergene Biotech Limited.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21258&type=smp
What Is Covered In The Pneumonia Therapeutics Global Market Report?
•Market Size Forecast: Examine the pneumonia therapeutics market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the pneumonia therapeutics market for a structured understanding.
•Key Players Overview: Analyze major players in the pneumonia therapeutics market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the pneumonia therapeutics market.
•Segment Contributions: Evaluate how different segments drive overall growth in the pneumonia therapeutics market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the pneumonia therapeutics market.
•Industry Challenges: Identify potential risks and obstacles affecting the pneumonia therapeutics market.
•Competitive Landscape: Review strategic developments in the pneumonia therapeutics market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Prominent Pneumonia Therapeutics Market Trend for 2025: Innovative Approaches To Combating Antibiotic Resistance In Pneumonia Treatment here
News-ID: 3934331 • Views: …
More Releases from The Business Research Company
Brake Lines Market Analysis: $36.58 Billion by 2029 With a CAGR of 3.5%
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
Brake Lines Market Value Projection: How Much Will the Market Size by 2025?
In recent times, the brake lines market has consistently seen growth. The market size is expected to escalate from $30.83 billion in 2024 to $31.88 billion in 2025, growing at a compound annual growth rate (CAGR) of 3.4%.…
Autonomous Vehicle Simulation Solutions Industry Set to Achieve $2.12 Billion Mi …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Long-Term Growth Forecast for the Autonomous Vehicle Simulation Solutions Market Size 2025?
The market size for autonomous vehicle simulation solutions has seen a rapid expansion in the past few years. The market, with a value of $0.96 billion in 2024, is projected to rise to $1.14 billion in 2025,…
Automotive Vehicle To Everything (V2X) Communications Industry Expected to Reach …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
Automotive Vehicle To Everything (V2X) Communications Market Value Projection: How Much Will the Market Size by 2025?
In recent years, the size of the automotive vehicle to everything (v2x) communications market has seen substantial growth. It is projected to increase from $3.6 billion in 2024 to $4.43 billion in 2025, registering…
Global Highway Driving Assist Market Worth $11.2 Billion by 2029, Growing at 20% …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Highway Driving Assist Market Outlook: What Size And CAGR Are Anticipated By 2025?
There has been a rapid expansion in the size of the highway driving assist market in the previous few years. Its projected growth is from $4.47 billion in 2024, escalating to $5.39 billion in 2025, with a…
More Releases for Pneumonia
Pneumonia Testing Market: Trends, Opportunities, and Challenges
The global pneumonia testing market is experiencing steady growth, valued at $1.6 billion in 2020 and projected to reach $3.0 billion by 2030, at a CAGR of 6.5% (2021-2030). Pneumonia, a serious respiratory infection, remains a leading cause of morbidity and mortality worldwide. With advancements in diagnostic technologies and increased healthcare awareness, the market for pneumonia testing is expanding rapidly.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/3776
Key Market Drivers
• Rise…
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current…
Market Definitions of Bacterial Pneumonia Treatment
Global Bacterial Pneumonia Treatment Market: Overview
Bacterial pneumonia is an inflammation of the lungs due to bacterial infection. Pneumonia is a common lung infection where the lung’s air sacks become inflamed. Different types of bacteria can cause pneumonia, but Streptococcus pneumonia and Haemophilus influenza are primarily responsible for most of the bacterial pneumonia. Common indications of bacterial pneumonia include cough, chest pain, shortness of breath, fever, and chills.
Read Report Overview -…
Industry Dynamics of Ventilator-associated Pneumonia
Ventilator associated pneumonia (VAP) is an intensive care unit (ICU) for acquired infection. This pulmonary infection generally occurs 48 hours after a patient is incubated and has received mechanical ventilation. Incidence of VAP ranges from 6% to 55% and can reach up to 76% in some situations. VAP is a major cause of illness and death. Patients suffering with VAP have increased spans of ICU hospitalization. Moreover, death rate has…
Global Interstitial Pneumonia Market Growth 2020-2025
Global Interstitial Pneumonia Market Overview:
The global Interstitial Pneumonia market is expected to grow at a significant pace, reports GLOBAL INFO RESEARCH. Its latest research report, titled [Global and United States Interstitial Pneumonia Market 2020 by Company, Type and Application, Forecast to 2025], offers a unique point of view about the global market. Analysts believe that the changing consumption patterns are expected to have a great influence on the overall market. For a…
Global Pneumonia Therapeutics Market 2018 – 2023
Global Pneumonia Therapeutics Market 2018–2023 Poised for xx% Growth
Planet Market Research has recently added a market study named Global Pneumonia Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023 with prime importance on the forecast period from 2018 to 2023. The report is an in-depth analysis of the market for pneumonia therapeutics and covers various driving factors, restraints, opportunities and challenges affecting the market’s growth.
Pneumonia is an…
